Compare LE & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LE | SGHT |
|---|---|---|
| Founded | 1963 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.6M | 309.6M |
| IPO Year | 1994 | 2021 |
| Metric | LE | SGHT |
|---|---|---|
| Price | $12.04 | $8.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $32.50 | $9.08 |
| AVG Volume (30 Days) | 173.6K | ★ 274.4K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.16 |
| EPS | ★ 10.56 | N/A |
| Revenue | ★ $1,162,769,000.00 | $77,363,000.00 |
| Revenue This Year | $5.53 | $11.67 |
| Revenue Next Year | $2.48 | $10.39 |
| P/E Ratio | $1.18 | ★ N/A |
| Revenue Growth | ★ 0.72 | N/A |
| 52 Week Low | $9.56 | $3.19 |
| 52 Week High | $20.04 | $9.24 |
| Indicator | LE | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 76.30 |
| Support Level | $9.91 | $8.00 |
| Resistance Level | $12.86 | $8.93 |
| Average True Range (ATR) | 0.46 | 0.55 |
| MACD | -0.10 | 0.14 |
| Stochastic Oscillator | 18.44 | 84.34 |
Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.